Company description

GKOS, or Glaukos Corporation, is a medical technology company that specializes in the development and commercialization of products designed to treat glaucoma. The company was founded in 1998 and is headquartered in San Clemente, California. Their flagship product is the iStent, which is a micro-bypass device that is inserted during cataract surgery and helps to improve the eye's natural fluid outflow, reducing eye pressure and potentially eliminating the need for glaucoma medication. Glaukos also offers a range of other products and therapies for the treatment of glaucoma, including laser technologies and implantable systems. The company has a strong and innovative research and development pipeline, with a focus on developing treatments for the early to moderate stages of glaucoma. In addition to their products, Glaukos also provides ongoing support and education for eye care professionals and patients, helping to raise awareness and improve outcomes for those living with glaucoma. With a global presence and strong financial performance, GKOS continues to lead the way in bringing innovative solutions to the market and improving the lives of those affected by glaucoma.